Total runs:
34.2K
Run Growth:
-5.8K
Growth Rate:
-16.85%
Sponsored by
APIMart
FreedomIntelligence / Apollo-1.8B
Model's Last Updated: April 26 2024
text-generation
Introduction of Apollo-1.8B
Model Details of Apollo-1.8B
Multilingual Medicine: Model, Dataset, Benchmark, Code
Covering English, Chinese, French, Hindi, Spanish, Hindi, Arabic So far
👨🏻💻
Github
•📃
Paper
• 🌐
Demo
• 🤗
ApolloCorpus
• 🤗
XMedBench
中文
|
English
🌈 Update
- [2024.03.07] Paper released.
- [2024.02.12] ApolloCorpus and XMedBench is published！🎉
- [2024.01.23] Apollo repo is published！🎉
Results
🤗 Apollo-0.5B • 🤗 Apollo-1.8B • 🤗 Apollo-2B • 🤗 Apollo-6B • 🤗 Apollo-7B
🤗 Apollo-0.5B-GGUF • 🤗 Apollo-2B-GGUF • 🤗 Apollo-6B-GGUF • 🤗 Apollo-7B-GGUF
Usage Format
User:{query}\nAssistant:{response}<|endoftext|>
Dataset & Evaluation
-
Dataset 🤗 ApolloCorpus
Click to expand
- Zip File
-
Data category
-
Pretrain:
-
data item:
- json_name: {data_source} {language} {data_type}.json
- data_type: medicalBook, medicalGuideline, medicalPaper, medicalWeb(from online forum), medicalWiki
- language: en(English), zh(chinese), es(spanish), fr(french), hi(Hindi)
- data_type: qa(generated qa from text)
-
data_type==text: list of string
[ "string1", "string2", ... ] -
data_type==qa: list of qa pairs(list of string)
[ [ "q1", "a1", "q2", "a2", ... ], ... ]
-
data item:
-
SFT:
- json_name: {data_source}_{language}.json
- data_type: code, general, math, medicalExam, medicalPatient
-
data item: list of qa pairs(list of string)
[ [ "q1", "a1", "q2", "a2", ... ], ... ]
-
Pretrain:
-
Evaluation 🤗 XMedBench
Click to expand
-
EN:
- MedQA-USMLE
- MedMCQA
- PubMedQA : Because the results fluctuated too much, they were not used in the paper.
-
MMLU-Medical
- Clinical knowledge, Medical genetics, Anatomy, Professional medicine, College biology, College medicine
-
ZH:
- MedQA-MCMLE
-
CMB-single
: Not used in the paper
- Randomly sample 2,000 multiple-choice questions with single answer.
-
CMMLU-Medical
- Anatomy, Clinical_knowledge, College_medicine, Genetics, Nutrition, Traditional_chinese_medicine, Virology
-
CExam
: Not used in the paper
- Randomly sample 2,000 multiple-choice questions
-
ES: Head_qa
-
FR: Frenchmedmcqa
-
HI: MMLU_HI
- Clinical knowledge, Medical genetics, Anatomy, Professional medicine, College biology, College medicine
-
AR: MMLU_Ara
- Clinical knowledge, Medical genetics, Anatomy, Professional medicine, College biology, College medicine
-
Results reproduction
Click to expand
Waiting for Update
Citation
Please use the following citation if you intend to use our dataset for training or evaluation:
@misc{wang2024apollo,
title={Apollo: Lightweight Multilingual Medical LLMs towards Democratizing Medical AI to 6B People},
author={Xidong Wang and Nuo Chen and Junyin Chen and Yan Hu and Yidong Wang and Xiangbo Wu and Anningzhe Gao and Xiang Wan and Haizhou Li and Benyou Wang},
year={2024},
eprint={2403.03640},
archivePrefix={arXiv},
primaryClass={cs.CL}
}
Runs of FreedomIntelligence Apollo-1.8B on huggingface.co
235
Total runs
1
24-hour runs
20
3-day runs
34
7-day runs
220
30-day runs
More Information About Apollo-1.8B huggingface.co Model
Url of Apollo-1.8B
Apollo-1.8B huggingface.co Url
Provider of Apollo-1.8B huggingface.co
Other API from FreedomIntelligence
Updated:January 17 2026
Total runs:
2.5K
Run Growth:
1.6K
Growth Rate:
65.41%
Total runs:
2.0K
Run Growth:
1.5K
Growth Rate:
74.88%
Total runs:
1.4K
Run Growth:
138
Growth Rate:
9.82%
Total runs:
1.4K
Run Growth:
919
Growth Rate:
65.88%
Total runs:
1.4K
Run Growth:
0
Growth Rate:
0.00%
Total runs:
1.3K
Run Growth:
640
Growth Rate:
48.45%
Total runs:
1.2K
Run Growth:
-311
Growth Rate:
-25.94%
Total runs:
1.1K
Run Growth:
934
Growth Rate:
87.29%
Total runs:
1.1K
Run Growth:
914
Growth Rate:
86.64%
Total runs:
920
Run Growth:
585
Growth Rate:
63.59%
Total runs:
841
Run Growth:
753
Growth Rate:
89.54%
Total runs:
679
Run Growth:
43
Growth Rate:
6.33%
Total runs:
643
Run Growth:
410
Growth Rate:
63.76%
Total runs:
601
Run Growth:
0
Growth Rate:
0.00%
Total runs:
569
Run Growth:
234
Growth Rate:
41.12%
Total runs:
530
Run Growth:
114
Growth Rate:
21.51%
Total runs:
392
Run Growth:
89
Growth Rate:
22.70%
Total runs:
375
Run Growth:
4
Growth Rate:
1.07%
Total runs:
353
Run Growth:
343
Growth Rate:
97.17%
Total runs:
252
Run Growth:
-23
Growth Rate:
-9.13%
Total runs:
247
Run Growth:
242
Growth Rate:
97.98%
Total runs:
241
Run Growth:
210
Growth Rate:
87.14%
Total runs:
238
Run Growth:
128
Growth Rate:
53.78%
Total runs:
228
Run Growth:
216
Growth Rate:
94.74%
Total runs:
206
Run Growth:
201
Growth Rate:
97.57%
Total runs:
204
Run Growth:
192
Growth Rate:
94.12%
Total runs:
202
Run Growth:
161
Growth Rate:
79.70%
Total runs:
200
Run Growth:
196
Growth Rate:
98.00%
Total runs:
198
Run Growth:
38
Growth Rate:
19.19%
Total runs:
186
Run Growth:
38
Growth Rate:
20.43%
Total runs:
182
Run Growth:
80
Growth Rate:
43.96%
Total runs:
180
Run Growth:
103
Growth Rate:
57.22%
Total runs:
165
Run Growth:
79
Growth Rate:
47.88%
Total runs:
161
Run Growth:
114
Growth Rate:
70.81%
Total runs:
134
Run Growth:
128
Growth Rate:
95.52%
Total runs:
124
Run Growth:
-36
Growth Rate:
-29.03%
Total runs:
119
Run Growth:
36
Growth Rate:
30.25%
Total runs:
115
Run Growth:
0
Growth Rate:
0.00%
Total runs:
111
Run Growth:
0
Growth Rate:
0.00%
Total runs:
103
Run Growth:
1
Growth Rate:
0.97%
Total runs:
89
Run Growth:
4
Growth Rate:
4.49%
Total runs:
74
Run Growth:
0
Growth Rate:
0.00%
Total runs:
73
Run Growth:
57
Growth Rate:
78.08%
Total runs:
70
Run Growth:
-244
Growth Rate:
-348.57%
Total runs:
66
Run Growth:
0
Growth Rate:
0.00%
Total runs:
57
Run Growth:
32
Growth Rate:
56.14%
Total runs:
53
Run Growth:
0
Growth Rate:
0.00%
Total runs:
50
Run Growth:
-858
Growth Rate:
-1716.00%
Total runs:
47
Run Growth:
-233
Growth Rate:
-495.74%
Total runs:
42
Run Growth:
18
Growth Rate:
42.86%
Total runs:
36
Run Growth:
5
Growth Rate:
13.89%
Total runs:
35
Run Growth:
28
Growth Rate:
80.00%
Total runs:
35
Run Growth:
0
Growth Rate:
0.00%
Total runs:
33
Run Growth:
-186
Growth Rate:
-563.64%
Total runs:
30
Run Growth:
25
Growth Rate:
83.33%
Total runs:
29
Run Growth:
27
Growth Rate:
93.10%
Total runs:
27
Run Growth:
16
Growth Rate:
59.26%
Total runs:
27
Run Growth:
4
Growth Rate:
14.81%
Total runs:
26
Run Growth:
-2
Growth Rate:
-7.69%
Total runs:
26
Run Growth:
0
Growth Rate:
0.00%
Total runs:
24
Run Growth:
9
Growth Rate:
37.50%
Total runs:
24
Run Growth:
-62
Growth Rate:
-258.33%
Total runs:
24
Run Growth:
0
Growth Rate:
0.00%
Total runs:
21
Run Growth:
6
Growth Rate:
28.57%
Total runs:
20
Run Growth:
-1
Growth Rate:
-5.00%
Total runs:
18
Run Growth:
4
Growth Rate:
22.22%
Total runs:
17
Run Growth:
12
Growth Rate:
70.59%
Total runs:
15
Run Growth:
0
Growth Rate:
0.00%
Total runs:
15
Run Growth:
0
Growth Rate:
0.00%
Total runs:
15
Run Growth:
9
Growth Rate:
60.00%
Total runs:
14
Run Growth:
4
Growth Rate:
28.57%
Total runs:
13
Run Growth:
9
Growth Rate:
69.23%
Total runs:
12
Run Growth:
1
Growth Rate:
8.33%
Total runs:
12
Run Growth:
11
Growth Rate:
91.67%
Total runs:
12
Run Growth:
-2
Growth Rate:
-16.67%
Total runs:
12
Run Growth:
0
Growth Rate:
0.00%
Total runs:
11
Run Growth:
6
Growth Rate:
54.55%
Total runs:
11
Run Growth:
0
Growth Rate:
0.00%
Total runs:
11
Run Growth:
-33
Growth Rate:
-300.00%
Total runs:
11
Run Growth:
5
Growth Rate:
45.45%
Total runs:
10
Run Growth:
-6
Growth Rate:
-60.00%
Total runs:
9
Run Growth:
-1
Growth Rate:
-11.11%
Total runs:
9
Run Growth:
-3
Growth Rate:
-33.33%
Total runs:
9
Run Growth:
3
Growth Rate:
33.33%
Total runs:
9
Run Growth:
5
Growth Rate:
55.56%
Total runs:
9
Run Growth:
-196
Growth Rate:
-2177.78%
Total runs:
8
Run Growth:
5
Growth Rate:
62.50%
Total runs:
8
Run Growth:
-40
Growth Rate:
-500.00%
Total runs:
8
Run Growth:
4
Growth Rate:
50.00%
Total runs:
8
Run Growth:
7
Growth Rate:
87.50%
Total runs:
8
Run Growth:
-8
Growth Rate:
-100.00%
Total runs:
8
Run Growth:
3
Growth Rate:
37.50%
Total runs:
7
Run Growth:
-4
Growth Rate:
-57.14%
Total runs:
7
Run Growth:
4
Growth Rate:
57.14%
Total runs:
7
Run Growth:
-3
Growth Rate:
-42.86%
Total runs:
7
Run Growth:
0
Growth Rate:
0.00%
Total runs:
5
Run Growth:
1
Growth Rate:
20.00%
Total runs:
5
Run Growth:
-22
Growth Rate:
-440.00%
Total runs:
5
Run Growth:
-2
Growth Rate:
-40.00%